<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">A perspective on sporadic inclusion-body myositis The role of aging and inflammatory processes</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">Caleb</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
							<email>cefinch@usc.edu</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Andrus Gerontology Center</orgName>
								<orgName type="department" key="dep2">Department of Biological Sciences</orgName>
								<orgName type="institution">University of Southern California</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Andrus Gerontology Center</orgName>
								<orgName type="department" key="dep2">Department of Biological Sciences</orgName>
								<orgName type="institution">University of Southern California</orgName>
								<address>
									<postCode>3715, 90089-0191</postCode>
									<settlement>McClintock, Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">A perspective on sporadic inclusion-body myositis The role of aging and inflammatory processes</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">F9195B054CCB6E2A8DA0192DB809E032</idno>
					<note type="submission">Received June 22, 2005. Accepted in final form October 14, 2005.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Sporadic inclusion-body myositis (sIBM) is an age-related condition manifested after midlife. This review points out salient features of sIBM that are shared with normal aging in muscle and with inflammatory changes in vascular atheromas and senile plaques of Alzheimer disease (AD). The amyloid precursor protein (APP) and derived Abeta peptides are found in both AD and sIBM. Because transgenic expression of human APP induces sIBM like changes, it is of potential interest that an inducer of APP, IL-1, increases during aging in mouse muscle. Because various subsets of the usual aging changes in aging brain, muscle, and vessels can be attenuated in rodents by caloric intake and possibly in humans by drugs with anti-inflammatory and anticoagulant activities, this study suggests that diet and inflammation may be useful experimental variations in exploring the pathogenesis of sIBM.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This brief review from a biogerontologist's perspective considers relationships between sporadic inclusion-body myositis (sIBM) and aging to further develop this important suggestion of Askanas and Engel <ref type="bibr" target="#b0">1</ref> (see also the article by <ref type="bibr">Engel and Askanas 1a</ref> in this issue). sIBM is considered the most common myopathy after age 50 years. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b2">2</ref> The hallmark of sIBM is the unexplained, slowly progressive muscle weakness in association with muscle fiber atrophy and vacuolation. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b3">3,</ref><ref type="bibr" target="#b4">4</ref> Inflammatory processes are present with consistent increase in the expression of IL-1beta and variable invasion of macrophages and T-cells. A potentially important variation is that the rare hereditary IBM (hIBM) cases show much less inflammation than in sIBM. <ref type="bibr" target="#b5">5</ref> Both types of IBM show cytochrome oxidase-negative (COX) fibers containing mutant mitochondria with various mtDNA deletions: hIBM <ref type="bibr" target="#b5">5</ref> and sIBM. <ref type="bibr" target="#b6">6,</ref><ref type="bibr" target="#b7">7</ref> Several major chronic diseases of aging are proving to share subsets of inflammatory processes that, to varying degrees, are also found in the same tis-sues in the absence of specific pathologic lesions, as discussed below. Shared inflammatory components, for example, arise in Alzheimer disease (AD) and vascular disease (VascD) (table 1; see also article by Murphy and Golde 7a in this issue). To some extent, the characteristic inflammatory changes in AD are intensifications of inflammatory changes that arise during normal aging in the absence of neurodegenerative disease (table <ref type="table" target="#tab_1">2</ref>). Because sIBM also includes inflammatory processes to varying degrees (see articles by Dalakas 7b and Steinman 7c in this issue), it is pertinent to consider the normal aging changes in skeletal muscle which include some markers of inflammation and oxidative stress (see article by Moreira 7d in this issue). Of course, cause and effect are hard to resolve (table <ref type="table" target="#tab_2">3</ref>).</p><p>IBM shares certain important features with AD, particularly the accumulations of the amyloid betapeptide (Abeta) and the amyloid precursor protein (APP) (see articles by Vetrive, <ref type="bibr">7e</ref> Murphy and Golde, <ref type="bibr">7a</ref> and Glabe and Kayed 7f in this issue). Note an important difference: in AD brains the Abeta accumulations are extracellular, whereas in sIBM Abeta is intracellular, within muscle fibers and there is no conspicuous extracellular Abeta depot. Transgenic overexpression of APP in vivo and in vitro gives valuable models for the key features of sIBM, with IM deposits of Abeta and phosphorylated tau. <ref type="bibr" target="#b14">[8]</ref><ref type="bibr" target="#b15">[9]</ref><ref type="bibr" target="#b16">[10]</ref> In addition, both AD and sIBM accumulate frameshifted ubiquitin (UBB ϩ 1) <ref type="bibr" target="#b17">11</ref> ; in sIBM, the location of the UBB ϩ 1 is intracellular, whereas in AD brains the UBB ϩ 1 is intraneuronal in dystrophic neurites and extracellular in senile plaques <ref type="bibr" target="#b18">12</ref> (see article by van Leeuwen 12a in this issue).</p><p>It may give insights to compare sIBM with AD and VascD. Although the incidence and prevalence by age are unknown, it is thought that sIBM incidence increases at later ages. <ref type="bibr" target="#b0">1</ref> Table <ref type="table" target="#tab_1">2</ref> approximates the age-related increase of sIBM prevalence, which may arise about 10 years before clinical symptoms of sporadic AD reach 1% prevalence in the population. Clinical VascD may reach a prevalence of 1% about 10 years before sIBM, such that patients Յ 40 years comprise 2% to 6% of the reported cases of acute myocardial infarction. <ref type="bibr" target="#b20">13</ref> What about preclinical stages? VascD is now widely thought to begin even before birth, with the presence of minute vascular lesions in fetal aortas that grow progressively even during childhood. <ref type="bibr" target="#b21">14,</ref><ref type="bibr" target="#b22">15</ref> The earliest AD changes that may be presymptom-atic arise in apoE4 carriers. ApoE4 is the most important genetic risk factor for AD, particularly in Caucasian and north Asian-derived populations (see article by Huang 15a in this issue). Importantly, apoE4 effects are not fully penetrant, because some E4/E4 homozygotes appear to reach advanced decades yet with intact cognition. By age 30 to 40 years, some apoE4 carriers have lower brain glucose metabolism, <ref type="bibr" target="#b24">16,</ref><ref type="bibr" target="#b25">17</ref> which may indicate the presence of emerging or congenital neuronal impairments, 20 or more years ahead of clinical disease. The apoE4 allele is proinflammatory in three situations: in vitro, apoE4 promotes the activation of complement by Abeta, <ref type="bibr" target="#b26">18</ref> whereas apoE3 but not E4 blocked the activation of brain macrophages by sAPP beta. <ref type="bibr" target="#b27">19</ref> After bypass surgery, apoE4 carriers had higher elevations of TNFalpha and IL-8. <ref type="bibr" target="#b28">20</ref> In mice with targeted replacement of apoE with the human alleles, E4 transgenic carriers had grater inflammatory responses. <ref type="bibr" target="#b29">[21]</ref><ref type="bibr" target="#b30">[22]</ref><ref type="bibr" target="#b31">[23]</ref> This proinflammatory activity may give a basis for interaction of the apoE genotype with the outcomes of sIBM, as discussed further below.</p><p>In AD, neurofibrillary changes increase exponentially at later decades <ref type="bibr" target="#b32">24,</ref><ref type="bibr" target="#b33">25</ref> ; the onset of NFT changes is speculated to be during adolescence. <ref type="bibr" target="#b34">26</ref> In the preclinical stages (CDR 0.5), nonfibrillar Abeta peptide (not an amyloid) is detected within neurons. <ref type="bibr" target="#b35">27</ref> Askanas and Engel 1 have suggested that accumulations of phosphorylated tau and Abeta are important steps in AD etiology that may be shared with sIBM. In particular, accumulations of APP and Abeta in muscle during sIBM appear to precede other abnormalities. Although apoE4 has not shown associations with sIBM, it remains possible that apoE alleles influence its course. For sIBM, the author cannot find discussion of preclinical stages. However, muscle fiber mitochondrial DNA deletions are clearly present in the general aging population, as discussed in more detail below.</p><p>It is not a digression to review some key points about APP and Abeta. The evolution of Abeta has enabled the robust transgenic models of IBM with human APP, because the rodent Abeta sequence differs from that of most vertebrates in three substitutions, denoted as human[residue number]rat, that reduce its aggregation: Arg [5]Gly, Tyr [10]Phenylal, Hist [13]Arg. <ref type="bibr" target="#b36">28,</ref><ref type="bibr" target="#b37">29</ref> Rat and mouse Abeta spontaneously aggregate into fibrils less avidly and lack the capacity to reduce Cu 2ϩ . <ref type="bibr" target="#b37">29</ref> Nonetheless, rodent Abeta can aggregate into soluble forms, possibly like the oligomers formed by human Abeta <ref type="bibr" target="#b38">30</ref> which cause stress and oxidative damage to cultured E18 neurons. Although dose-responses were not characterized, it appears that rat Abeta aggregates are less toxic. <ref type="bibr" target="#b37">29</ref> This major difference in human and rodent Abeta aggregability has enabled the success of human transgenic Abeta, mutant and wild type, in rodent models. An open question in sIBM transgenic is the role of soluble toxic Abeta forms and hybrid human-rodent Abeta structures (see article by Glabe and Kayed 7f in this issue). The evolutionary depth of the toxic Abeta sequence is remarkable, extending at least 300 million years back into the paleozoic vertebrate stem lines: fish <ref type="bibr" target="#b39">31,</ref><ref type="bibr" target="#b40">32</ref> and the great apes and humans <ref type="bibr" target="#b41">33</ref> have functionally equivalent Abeta sequences. Although aging rodent brains do show some accumulation of their endogenous Abeta sequence during aging, the increases are modest and no amyloid fibrils are formed. <ref type="bibr" target="#b42">34,</ref><ref type="bibr" target="#b43">35</ref> On this basis, the author suggests that sIBM will be less common in wild type aging rodents than humans, whereas aging primates should also show sIBM because of their similar APP sequence to humans.</p><p>The functions of APP and Abeta are not known, despite their presence at some level in cell throughout the body. There is ongoing discussion about the role of APP in normal brain memory processes. In normal muscle, APP is constitutively expressed, such as in mouse and human neuromuscular junction and in myoblasts. <ref type="bibr" target="#b44">36,</ref><ref type="bibr" target="#b45">37</ref> Intracellular APP may have roles as serine protease inhibitors from the Kunitz-motif in the APP which occurs widely in mammalian APP (see article by Engel and Askanas 1a in this issue).</p><p>A large and growing literature describes interactions of APP with apoptosis. APP is rapidly induced in response to injury and stress in a wide variety of cells. In the chloroquine rat myopathy model (not a model of IBM), Abeta was increased during formation of the abnormal snake-coiled myofibers. <ref type="bibr" target="#b46">38</ref> In lymphoblastoid cultures from humans, the induction of APP mRNA by heat shock treatment followed induction of HSP70 mRNA. <ref type="bibr" target="#b47">39</ref> Neurons are the cell type best characterized for stress-induced APP. <ref type="bibr" target="#b47">39,</ref><ref type="bibr" target="#b48">40</ref> In evolutionary terms, APP may be a candidate for antagonistic pleiotropy, as a gene with some advantages during early life or in response to acute stress, with delayed adverse consequences. Because APP induction is a general cellular response to injury and stress, <ref type="bibr" target="#b49">41</ref> one may consider the possibility that in sIBM the induction of APP is secondary to a prior cell-stress state, such as mtDNA deletions or the induction of IL-1, as discussed next.</p><p>Several muscle changes of normal aging are pertinent to sIBM. The most obvious is the progressive increase of mtDNA deletions in aging skeletal muscle and cardiac muscle, which are localized to COXnegative fibers <ref type="bibr" target="#b50">[42]</ref><ref type="bibr" target="#b51">[43]</ref><ref type="bibr" target="#b52">[44]</ref> (see article by Oldfors 44a in this issue). Thus, aging skeletal muscle becomes a mosaic of fibers with a spectrum of mtDNA deletions. <ref type="bibr" target="#b54">45</ref> Because similar COX-negative fibers with mtDNA deletions are also a hallmark of sIBM, the author suggests the hypothesis that sIBM arises in such COX-negative fibers.</p><p>Gene expression age changes in normal skeletal muscle are also cogent to sIBM. According to one study (perhaps the only) of muscle cytokines and normal aging, the aging mouse shows threefold increases of IL-1beta expression (2 vs 24 months, female C57BL/6 mice), assayed by ELISA in muscle lysates (the muscle was not specified); <ref type="bibr" target="#b55">46</ref> IL-1beta immunoreactivity was detected diffusely in myocytes (data not shown). If verified, these findings are of much importance of the prominent elevations of IL-1 within the lesions of sIBM. The APP mRNA showed minor, non-significant increases in extracts of gastrocnemius muscle from 2-year-old mice (Tom Prolla and Jim Vann, personal communication, University of Wisconsin).</p><p>Dalakas <ref type="bibr" target="#b4">4</ref> has hypothesized that IL-1 in sIBM drives the expression of APP, which extends the hypothesis of Griffin and colleagues, <ref type="bibr" target="#b56">47,</ref><ref type="bibr" target="#b57">48</ref> who first proposed for AD that IL-1 induces APP in brain cells (see article by Dalakas 7b in this issue). Drawing on these concepts, the author suggests that mtDNA deletions could be the initiating event, with subsequent cell stress that induces IL-1 and APP in a feedforward cascade. Although average muscle APP did not increase with aging, it would still be worth a look at APP expression at a cell level by immunohistochemistry or in situ hybridization, because larger increases might be found in damaged fibers, especially those with mtDNA deletions. Aging mice may not be as prone to sIBM as humans because rodent Abeta is less amyloidogenic and cytotoxic as noted above.</p><p>Several other aging changes also map into sIBM pathogenesis. The aging mouse gastrocnemius (5 vs 30 months C57BL/6 male) shows two-to fourfold decreases of mRNAs for several enzymes of protein catabolism: mitochondrial LON protease, ubiquitin thiolesterase, and ubiquitin specific protease. <ref type="bibr" target="#b58">49</ref> If the protein activities are also decreased, these changes could enable the increase of UBB ϩ 1 in sIBM (see article by van Leeuwen 12a in this issue). Genes showing increased expression include the two to fourfold increase of Hsp 27 and Hsp 71; SAA isoform 4; and PPRgamma. Hsp27 is significant because it binds actin. In aging heart of sedentary mice, several inflammatory genes are increased (complement C1q; TNF receptor6, and apoE. <ref type="bibr" target="#b59">50</ref> Aging human muscle (vasa lateralis) also shows increase of HSP27. <ref type="bibr" target="#b60">51</ref> IL-6 also increased in aging mouse muscle. <ref type="bibr" target="#b61">52</ref> Each of these changes could be relevant to the milieu of aging which enables sIBM and its local inflammatory processes.</p><p>IL-1 and IL-6 also increase in other tissues during aging. <ref type="bibr" target="#b61">[52]</ref><ref type="bibr" target="#b62">[53]</ref><ref type="bibr" target="#b63">[54]</ref><ref type="bibr" target="#b64">[55]</ref> For example, we observed increased IL-6 in mRNA and protein in aging rat glia at baseline (no stimulation; figure); although IL-1 expression was not different in unstimulated glia, stimulation by LPS (endotoxin) increased IL-1 and IL-6 expression more in old glia. <ref type="bibr" target="#b62">53</ref> Blood levels of these cytokines also increase markedly during aging in human populations, in association with sub-populations experiencing poor health from heart disease and other causes as described for IL-1 <ref type="bibr" target="#b65">56,</ref><ref type="bibr" target="#b66">57</ref> and particularly for IL-6. <ref type="bibr" target="#b67">58</ref> The "inflammatory burden" is being recognized as a general indicator of function and future risk of morbidity. <ref type="bibr" target="#b68">[59]</ref><ref type="bibr" target="#b69">[60]</ref><ref type="bibr" target="#b70">[61]</ref><ref type="bibr" target="#b71">[62]</ref> A remarkable and unexpected generalization may be at hand: anti-inflammatory drugs and statins give general protection against chronic diseases of aging. It is now widely accepted that vascular disease, either first event or recurrence, is lowered 30% to 50% by aspirin and statins. Moreover, several cancers are similarly decreased by NSAIDs (colorectal and esophageal), and there may be a benefit of aspirin and statins to risk of breast cancer. The possibility of benefits to AD from NSAIDs, aspirin, and statins is under intense study. <ref type="bibr" target="#b72">[63]</ref><ref type="bibr" target="#b73">[64]</ref><ref type="bibr" target="#b74">[65]</ref><ref type="bibr" target="#b75">[66]</ref><ref type="bibr" target="#b76">[67]</ref> The impact of these widely used drugs may be influenced by the apoE genotype, because apoE4 allele is proinflammatory as noted above.</p><p>Caloric restriction is another anti-inflammatory paradigm <ref type="bibr" target="#b77">68</ref> that may be useful experimental manipulations in the transgenic sIBM models. Caloric restriction attenuates mtDNA deletions and muscle fiber loss in rodent models. <ref type="bibr" target="#b78">69</ref> The mechanism may be to lower blood glucose, because mtDNA deletions in skeletal muscle are accelerated by chronic hyperglycemia in humans in proportion to the duration of diabetes <ref type="bibr" target="#b79">70,</ref><ref type="bibr" target="#b80">71</ref> and in rodent smooth muscle. <ref type="bibr" target="#b81">72</ref> Caloric restriction also increases expression of genes for freeradical scavenging in muscle mitochondria. <ref type="bibr" target="#b82">73</ref> Because these same variations also influence the amount of 8-hydroxyguanosine (8-OHG) in mtDNA, it is hypothesized that blood glucose influences the rate of mtDNA oxidation. <ref type="bibr" target="#b81">72,</ref><ref type="bibr" target="#b83">74</ref> Besides COX-negative fibrils and 8-OHG, caloric restriction also attenuates markers of oxidative stress in aging muscle and other tissues (see articles by Buxbaum, <ref type="bibr">74a</ref> Davies and Shrinagpure, <ref type="bibr">74b</ref> and Moriera et al. <ref type="bibr">7d</ref> in this issue).</p><p>The author concludes with several suggestions for future studies on sIBM based on this brief review:</p><p>1. Close examination of the overlap between normal aging changes in muscle and the characteristics of sIBM, particularly mtDNA deletions and COXnegative fibrils and the expression of IL-1 and APP. Herein may be found the 'age milieu' for sIBM. <ref type="bibr" target="#b0">1</ref> It might be predicted that earliest stages of sIBM arise in COX-negative muscle fibers and that APP inductions are subsequent, because of evidence that elevated IL-1beta induces APP. 2. In sIBM, transgenics define the role of soluble toxic Abeta forms and hybrid human-rodent Abeta structures. 3. The influence of blood glucose levels on the onset and progression of sIBM in transgenic APP models, in vivo and in vitro. 4. Relationship of sIBM to other inflammatory processes and diseases of aging. 5. The influence of salicylate, NSAIDs and statins on models of sIBM and in human populations. 6. The influence of apoE4 alleles on the inflammatory aspects of sIBM in human patients and in apoE allele targeted replacement mice. 7. Comparative studies on sIBM with aging, which should be rare in rodents because of their divergent APP sequence, but like humans in primates because of their similar APP sequence.  <ref type="bibr" target="#b62">53</ref> </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure .</head><label>.</label><figDesc>Figure.Aging increases expression of IL-6 in rat mixed glial cultures. IL-6 expression in rat primary mixed glial cultures from 3-month-old (young) or 24-month-old (old) male rat brain regions, expressed as ratio of old/young. IL-6 protein, left bars; IL-6 mRNA, right bars. Cx ϭ cortex; Hc ϭ hippocampus; St ϭ striatum. Adapted from Xie et al.<ref type="bibr" target="#b62">53</ref> </figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>Shared inflammatory mechanisms</figDesc><table><row><cell></cell><cell>Atheroma</cell><cell>Senile plaque</cell><cell>IBM</cell></row><row><cell>Cells</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Macrophages (CD68)</cell><cell>ϩϩϩ</cell><cell>ϩϩ</cell><cell>ϩ/Ϫ</cell></row><row><cell>T helper (Th1)-cells</cell><cell>ϩϩ</cell><cell>0</cell><cell>ϩ/Ϫ</cell></row><row><cell>Mast cells, platelets</cell><cell>ϩϩ</cell><cell>0</cell><cell>?</cell></row><row><cell>Neovascularization</cell><cell>ϩϩ</cell><cell>ϩ</cell><cell>?</cell></row><row><cell>Proteins</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Amyloid Abeta/APP</cell><cell>ϩϩ APP</cell><cell>ϩϩϩ</cell><cell>ϩϩϩ</cell></row><row><cell>C-reactive protein</cell><cell>ϩϩ</cell><cell>ϩ</cell><cell>?</cell></row><row><cell>Serum amyloid P</cell><cell>ϩϩ</cell><cell>ϩϩ</cell><cell>?</cell></row><row><cell>Clotting factors</cell><cell>ϩϩ</cell><cell>0</cell><cell>?</cell></row><row><cell>Complement: C3, C5b-9</cell><cell>ϩϩ</cell><cell>ϩϩ</cell><cell>?</cell></row><row><cell>Cytokines: IL-1</cell><cell>ϩ</cell><cell>ϩ ϩ</cell><cell>ϩ ϩ</cell></row><row><cell>References 1,3,75,76.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc>Inflammatory markers in Alzheimer disease and usual brain aging</figDesc><table><row><cell></cell><cell>Senile</cell><cell>Aging</cell><cell>Aging</cell></row><row><cell></cell><cell>plaque</cell><cell>human</cell><cell>rodent</cell></row><row><cell>Glial activation astrocytes;</cell><cell>ϩϩ</cell><cell>ϩ</cell><cell>ϩ</cell></row><row><cell>microglia-monocytes</cell><cell></cell><cell></cell><cell></cell></row><row><cell>␣1-antichymotrypsin</cell><cell>ϩ</cell><cell></cell><cell></cell></row><row><cell>␣2-macroglobulin</cell><cell></cell><cell></cell><cell></cell></row><row><cell>apoE, apoJ</cell><cell>ϩϩ</cell><cell>ϩ</cell><cell>ϩ</cell></row><row><cell>Complement C1q, C3</cell><cell>ϩ</cell><cell>Corpora amylaceae</cell><cell>ϩ</cell></row><row><cell>IL-1, Il-6, TNF-␣</cell><cell>ϩ ϩ</cell><cell>ϩ</cell><cell>ϩ</cell></row><row><cell>References 75,77.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc>Schedules of chronic diseases of aging</figDesc><table><row><cell></cell><cell>0 -10 years</cell><cell>10 -30 years</cell><cell>30 -50 years</cell><cell>50 -70 years</cell><cell>Ͼ70 years</cell></row><row><cell>Vascular plaques</cell><cell>ϩ</cell><cell>ϩ</cell><cell>ϩϩ</cell><cell>ϩϩϩ</cell><cell>ϩϩϩ</cell></row><row><cell>Alzheimer amyloid</cell><cell>0</cell><cell>?</cell><cell>ϩ (apoE4)</cell><cell>ϩϩ</cell><cell>ϩϩϩ</cell></row><row><cell>sIBM</cell><cell></cell><cell>?</cell><cell>?</cell><cell>ϩ</cell><cell>ϩ ?</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0">January 2006 NEUROLOGY 66(Suppl 1) S3</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgment</head><p>The author thanks Valarie Askanas and W. King Engel for the enlightening discussions on the potential significance of sIBM in aging and its shared traits with AD.</p></div>
			</div>


			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Supported by the Alzheimer's Association, by the John Douglas French Alzheimer's Foundation, and by the National Institute on Aging (AG13499). Disclosure: The author is co-founder and major stockholder of Acumen Pharmaceuticals, which develops therapies for Alzheimer disease. The author reports no conflicts of interest.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="737" to="744" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis: clinical, diagnostic, and pathologic aspects</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S20" to="S29" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Transthyretin Val122Ile, accumulated Abeta, and inclusion-body myositis aspects in cultured muscle</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="257" to="260" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="561" to="567" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Molecular immunology and genetics of inflammatory muscle diseases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1509" to="1512" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Darin</forename><forename type="middle">N</forename><surname>Kyllerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martinsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wahlstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="23" to="28" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Molnar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schroder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="41" to="51" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Horvath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Johns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Genge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Shoubridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="396" to="403" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Golde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S65" to="S68" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Inflammatory, immune, and viral aspects of inclusionbody myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S33" to="S38" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Controlling autoimmunity in sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Steinman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S56" to="S58" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Brain and brawn: parallels in oxidative strength</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Moreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S97" to="S101" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Amyloidogenic processing of ␤-amyloid precursor protein in intracellular compartments</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Vetrivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thinakaran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S69" to="S73" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Glabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kayed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S74" to="S78" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer&apos;s disease? Clues from inclusion-body myositis, cultured human muscle, and transgenic mice</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1673" to="1677" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Hearn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Ogburn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1679" to="1686" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Fukuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lindsey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1687" to="1693" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Mutant ubiquitin UBBϩ1 is accumulated in sporadic inclusion-body myositis muscle fibers</title>
		<author>
			<persName><forename type="first">P</forename><surname>Fratta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Van Leeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Hol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1114" to="1117" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer&apos;s and Down patients</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Van Leeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>De Kleijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Van Den Hurk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="242" to="247" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Van Leeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Tijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maf</forename><surname>Sonnemans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S86" to="S92" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Long-term prognosis of patients having acute myocardial infarction when Յ40 years of age</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Fournier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cabezon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cayuela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ballesteros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cortacero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Diaz</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>Llera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="989" to="992" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>D'armiento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Nigris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="2472" to="2479" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Napoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Palinski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="293" to="302" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Apolipoprotein E and Alzheimer disease</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S79" to="S85" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer&apos;s dementia</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Reiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Alexander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="284" to="289" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Brain-imaging surrogate markers for detection and prevention of age-related memory loss</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Small</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Neurosci</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="17" to="21" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Mcgeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Pitas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Mahley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Mcgeer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">749</biblScope>
			<biblScope unit="page" from="135" to="138" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Barger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Harmon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="878" to="881" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines</title>
		<author>
			<persName><forename type="first">N</forename><surname>Drabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Grunenfelder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="609" to="613" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Sex steroids, APOE genotype and the innate immune system</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Colton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Vitek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="363" to="372" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">APOE genotype-specific differences in human and mouse macrophage nitric oxide production</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Colton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Needham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="62" to="67" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Apolipoprotein E isoform mediated regulation of nitric oxide release</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Colton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Laskowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Vitek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Free Radic Biol Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1071" to="1075" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Neuropathological stageing of Alzheimer-related changes</title>
		<author>
			<persName><forename type="first">H</forename><surname>Braak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Braak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta neuropathologica</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Tangles and plaques in nondemented aging and &quot;preclinical</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="358" to="368" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>Alzheimer&apos;s disease</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer&apos;s diseaserelated neurofibrillary changes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Ohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Me `uller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Braak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bohl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="209" to="217" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Intraneuronal Abeta42 accumulation in human brain</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Gouras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Naslund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="15" to="20" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Conservation of the sequence of the Alzheimer&apos;s disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Johnstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Chaney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Norris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pascual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Little</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res. Mol Brain Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="299" to="305" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity</title>
		<author>
			<persName><forename type="first">D</forename><surname>Boyd-Kimball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sultana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mohmmad-Abdul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Butterfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Alz Dis</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="515" to="525" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Targeting small Abeta oligomers: the solution to an Alzheimer&apos;s disease conundrum?</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Krafft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Neurosci</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="219" to="224" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development</title>
		<author>
			<persName><forename type="first">A</forename><surname>Musa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lehrach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Russo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dev Genes Evol</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="page" from="563" to="567" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">cDNA isolation of Alzheimer&apos;s amyloid precursor protein from cholinergic nerve terminals of the electric organ of the electric ray</title>
		<author>
			<persName><forename type="first">K</forename><surname>Iijima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Okutsu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">330</biblScope>
			<biblScope unit="page" from="29" to="33" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Meat-adaptive genes and the evolution of slower aging in humans</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Stanford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Q Rev Biol</title>
		<imprint>
			<biblScope unit="page" from="3" to="50" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Aging, gender and APOE isotype modulate metabolism of Alzheimer&apos;s Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Petanceska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Montine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1011" to="1018" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid betaprotein 42 in the brain</title>
		<author>
			<persName><forename type="first">F</forename><surname>Oyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sawamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kobayashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="313" to="322" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Neurotrophic regulation of mouse muscle beta-amyloid protein precursor and alpha 1-antichymotrypsin as revealed by axotomy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Akaaboune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Festoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hantai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurobiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="503" to="514" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Serine proteinase inhibitors in human skeletal muscle: expression of beta-amyloid protein precursor and alpha 1-antichymotrypsin in vivo and during myogenesis in vitro</title>
		<author>
			<persName><forename type="first">M</forename><surname>Akaaboune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Verdiere-Sahuque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lachkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Festoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hantai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="503" to="511" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Snake coiled fibres in rat soleus muscle in chloroquine induced myopathy share immunohistochemical characteristics with amyloid depositions in Alzheimer&apos;s disease brain tissue</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tsuzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fukatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Takamaru</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Exp Pathol</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Abe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">St</forename><surname>George-Hyslop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Tanzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Kogure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="169" to="171" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Amyloid precursor protein (APP) and its derivatives change after cellular energy depletion. An in vitro-study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hoyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Bardenheuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Plaschke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neural Transm</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="239" to="253" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The functions of the amyloid precursor protein gene</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Panegyres</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Neurosci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1" to="39" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">An age-associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kopsidas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kovalenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kelso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Linnane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutation Res</title>
		<imprint>
			<biblScope unit="volume">421</biblScope>
			<biblScope unit="page" from="27" to="36" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Tissue mitochondrial DNA changes. A stochastic system</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kopsidas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kovalenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Heffernan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann NY Acad Sci</title>
		<imprint>
			<biblScope unit="volume">908</biblScope>
			<biblScope unit="page" from="226" to="243" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Stochastic mitochondrial DNA changes: bioenergy decline in type I skeletal muscle fibres correlates with a decline in the amount of amplifiable full-length mtDNA</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kopsidas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yarovaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biogerontology</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="29" to="36" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Mitochondrial abnormalities in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A-R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jonasson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S49" to="S55" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Is defective electron transport at the hub of aging?</title>
		<author>
			<persName><forename type="first">E</forename><surname>Maklashina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Ackrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aging Cell</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="21" to="27" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Different patterns of interleukin-1alpha and interleukin-1beta expression in organs of normal young and old mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hacham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>White</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Cytokine Network</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="55" to="65" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Stanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="7611" to="7615" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Glia and their cytokines in progression of neurodegeneration</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Mrak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Griffin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="349" to="354" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Gene expression profile of aging and its retardation by caloric restriction</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Klopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Weindruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Prolla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="1390" to="1393" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Lifelong voluntary exercise in the mouse prevents age-related alterations in gene expression in the heart</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bronikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Genomics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="129" to="138" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Aged human muscle demonstrates an altered gene expression profile consistent with an impaired response to exercise</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Jozsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Dupont-Versteegden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Taylor-Jones Jm</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mech Ageing Dev</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="45" to="56" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Interleukin-6 and interleukin-10 are expressed in organs of normal young and old mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hacham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Argov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Cytokine Network</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="37" to="46" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rozovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="page" from="135" to="141" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Increased IL-1beta in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">O</forename><surname>Maher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Lynch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="795" to="806" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Increased interleukin-6 expression by microglia from brain of aged mice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="139" to="148" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Self-rated health is related to levels of circulating cytokines</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lekander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elofsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Neve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">O</forename><surname>Hansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Unden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychosom Med</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="559" to="563" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Serum IL-1beta levels in health and disease: a population-based study</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Iorio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ferrucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sparvieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytokine</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="198" to="205" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>The InCHIANTI study</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Inflammatory markers and the risk of coronary heart disease in men and women</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Pai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pischon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page" from="2599" to="2610" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">The effects of serum beta-carotene concentration and burden of inflammation on all-cause mortality risk in high-functioning older persons: MacArthur studies of successful aging</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Reuben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Crimmins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Seeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gerontol A Biol Sci Med Sci</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="849" to="854" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Weaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Rowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Seeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="371" to="378" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Georges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Rupprecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blankenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="515" to="521" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Cytokines and cognition-the case for a head-to-toe inflammatory paradigm</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="2041" to="2056" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Nonsteroidal antiinflammatory drugs for the prevention of Alzheimer&apos;s disease: a systematic review</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Szekely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Thorne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Zandi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroepidemiology</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="159" to="169" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Convergence of atherosclerosis and Alzheimer&apos;s disease: inflammation, cholesterol, and misfolded proteins</title>
		<author>
			<persName><forename type="first">I</forename><surname>Casserly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Topol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="1139" to="1146" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Glidzic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stevanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Stefanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dukic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mitrovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Radivojevic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hemorrhoids. Med Glas</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="248" to="257" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Inflammation and Alzheimer&apos;s disease pathogenesis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Lue</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="681" to="686" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer&apos;s disease?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Breitner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Zandi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="page" from="1567" to="1568" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">The glucocorticoid paradox of caloric restriction in slowing brain aging</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiology of Aging</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="707" to="717" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Aspnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Weindruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Roecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Aiken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="573" to="581" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Oxidative damage to mitochondrial DNA and its relationship to diabetic complications</title>
		<author>
			<persName><forename type="first">S</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hinokio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Komatu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="161" to="168" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress</title>
		<author>
			<persName><forename type="first">P</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Fukagawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="920" to="923" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Aging and high concentrations of glucose potentiate injury to mitochondrial DNA</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Fukagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Absher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Free Radic Biol Med</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1437" to="1443" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Effects of caloric restriction on mitochondrial function and gene transcripts in rat muscle</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sreekumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Unnikrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page" from="E38" to="43" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Aging in vertebrates, and the effect of caloric restriction: a mitochondrial free radical production-DNA damage mechanism?</title>
		<author>
			<persName><forename type="first">G</forename><surname>Barja</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Rev Camb Philos Soc</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="235" to="251" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Treatment and prevention of the amyloidoses</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Buxbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S110" to="S113" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases</title>
		<author>
			<persName><forename type="first">Kja</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shringarpure</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S93" to="S96" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Developmental origins of aging in brain and blood vessels: an overview</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="281" to="292" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Complement activation in very early Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zanjani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Finch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kemper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alz Dis Assoc Disorders</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="55" to="66" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Microglia and aging in the brain</title>
		<author>
			<persName><forename type="first">C</forename><surname>Finch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rozovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Weindruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Prolla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Microglia in the Regenerating and Degenerating Central Nervous System</title>
				<editor>
			<persName><forename type="first">W</forename><surname>Streit</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Springer-Verlag</publisher>
			<date type="published" when="2002">2002</date>
			<biblScope unit="page" from="275" to="305" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
